Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) EBT Margin Growth (5y) (2016 - 2025)

Analysis

Abeona Therapeutics (ABEO) EBT Margin Growth (5y) (2016 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14,748.00
Jun 30, 2023 413,138.00
Dec 31, 2022 -1.37 Mn
Jun 30, 2022 299,741.00
Mar 31, 2022 -318,828.00
Dec 31, 2020 55,944.00
Sep 30, 2020 202,266.00
Dec 31, 2018 99,391.00
Sep 30, 2018 -56,603.00
Jun 30, 2018 -403,137.00
Mar 31, 2018 -194,612.00
Dec 31, 2017 -552,141.00
Sep 30, 2017 -232,136.00
Jun 30, 2017 -358,028.00
Mar 31, 2017 -277,432.00
Dec 31, 2016 -228,394.00
Sep 30, 2016 -135,519.00
Jun 30, 2016 -139,491.00
Mar 31, 2016 -81,848.00